Cargando…
Eprosartan mesylate, an angiotensin II receptor antagonist
The title compound, eprosartan mesylate {systematic name: 2-butyl-1-(4-carboxybenzyl)-5-[(E)-2-carboxy-3-(thiophen-2-yl)prop-1-enyl]-1H-imidazol-3-ium methanesulfonate}, C(23)H(25)N(2)O(4)S(+)·CH(3)O(3)S(−), one of the angiotensin II-receptor antagonists, is effective in regulating hypertensi...
Autores principales: | Qian, Jing-Jing, Hu, Xiu-Rong, Gu, Jianming, Wu, Su-Xiang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099799/ https://www.ncbi.nlm.nih.gov/pubmed/21754064 http://dx.doi.org/10.1107/S1600536811006659 |
Ejemplares similares
-
Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker
por: Blankestijn, P. J, et al.
Publicado: (2008) -
Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate
por: Ahad, Abdul, et al.
Publicado: (2017) -
Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology
por: Ahad, Abdul, et al.
Publicado: (2022) -
Development and Validation of a UV Spectrophotometric Method for the Simultaneous Estimation of Eprosartan Mesylate and Hydrochlorothiazide in Bulk and Formulations
por: Anandakumar, K., et al.
Publicado: (2011) -
Moxifloxacinium chloride monohydrate
por: Qian, Jing-Jing, et al.
Publicado: (2011)